Ticker: FATE

Company: FATE THERAPEUTICS INC

Person: CINDY TAHL, officer

Transaction date: Jan. 9, 2026

Reporting date: Jan. 12, 2026

Average share price: 1.0648

Sold 10589.0 shares for 11275.17